Jump to: [Chinese Items]   [0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] or enter the first few letters:

Showing items 9051-9100 of 12927. (259 Page(s) Totally) << < 177 178 179 180 181 182 183 184 185 186 > >> View [10|25|50] records per page

Date	Title	Relation
2012-02	Phase I study of biweekly liposome irinotecan (PEP02, MM-398) in metastatic colorectal cancer failed on firstline oxaliplatin-based chemotherapy	Journal of Clinical Oncology. 2012 Feb;30(4):613.
2021-05	Phase I study of H3B-6527 in hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC)	Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 4090.
2010-05	Phase I study of liposome irinotecan (PEP02) in combination with weekly infusion of 5-FU/LV in advanced solid tumors	Journal of Clinical Oncology. 2010 May;28(15):Abstract Number e13024.
2015-03	Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients	Cancer Chemotherapy and Pharmacology. 2015 Mar;75(3):579-586.
2002	A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer	Oncology. 2002;63(3):239-247.
2016-02	Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC)	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 369.
2013-05	A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine	Vaccine. 2013 May;31(20):2471-2476.
2006-03	Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer	Journal of Gastroenterology and Hepatology. 2006 Mar;21(3):531-536.
2008-05	Phase I/II study of capecitabine and PHY906 in hepatocellular carcinoma	Journal of Clinical Oncology. 2008 May;26(15 Suppl):Abstract number 4610.
2018-05	A phase Ib study of ADI-PEG 20 plus pembrolizumab in advanced solid cancers	Journal of Clinical Oncology. 2018 May;36(15, Suppl. S):Meeting Abstract 2556.
2011-08-17	A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan	Cancer Chemotherapy and Pharmacology. 2011 Aug 17;67(6):1281-1289.
2002-05	Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients	Cancer Chemotherapy and Pharmacology. 2002 May;49(5):425-428.
2014-07	Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer	Oncology. 2014 Jul;87(2):104-113.
2007-05	Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy	Cancer. 2007 May;109(9):1821-1828.
2006-02	A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly	Journal of Thoracic Oncology. 2006 Feb;1(2):141-145.
2008-08	A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly	Lung Cancer. 2008 Aug;61(2):214-219.
2008-01	Phase II randomized study of weekly docetaxel alone or plus UFUR treatment in non-small cell lung cancer patients who failed previous chemotherapy	Lung Cancer. 2008 Jan;59(1):64-68.
2009-05-20	Phase II randomized trial of erlotinib versus vinorelbine in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) aged >= 70 years in Taiwan	Journal of Clinical Oncology. 2009 May 20;27(15s):Abstract number 8051.
2017-09	A phase II study of Arginine Deiminase (ADI-PEG20) in relapsed/refractory or poor-risk acute myeloid leukemia patients	Scientific Reports. 2017 Sep;7:Article number 11253.
2018-01	Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma	Journal of Clinical Oncology. 2018 Jan;36(3):276-282.
2009-11	Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer	Cancer Chemotherapy and Pharmacology. 2009 Nov;64(6):1173-1179.
2012-02	Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma	International Journal of Radiation Oncology, Biology, Physics. 2012 Feb;82(2):817-825.
2002-10	Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy	American Journal of Clinical Oncology. 2002 Oct;25(5):509-512.
2003-02	Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel	Lung Cancer. 2003 Feb;39(2):209-214.
2000	Phase II study of docetaxel plus gemcitabine in patients with non-small cell lung cancer (NSCLC) that failed previous chemotherapy (CT)	Annals of Oncology. 2000;11:522P.
2003-12	Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy	American Journal of Clinical Oncology. 2003 Dec;26(6):567-570.
2006-01	Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma	Head and Neck. 2006 Jan;28(1):74-80.
2009-05-20	A phase II study of gemcitabine-based chemoradiotherapy (CCRT) after triplet induction chemotherapy (ICT) for locally advanced pancreatic cancer (LAPC): A Taiwan Cooperative Oncology Group (TCOG) study	Journal of Clinical Oncology. 2009 May 20;27(15):Abstract number e15562.
1997-04	Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer	Japanese Journal of Clinical Oncology. 1997 Apr;27(2):76-79.
2011-09	Phase II study of low-dose everolimus plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for first-line treatment of metastatic or recurrent gastric cancers	European Journal of Cancer. 2011 Sep;47(Suppl 1):S467.
2011-09-23	A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou	European Journal of Cancer. 2011 Sep 23;47:S547-S548.
2000-08	Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy	Lung Cancer. 2000 Aug;29(2):139-146.
2010-10	A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer	British Journal of Cancer. 2010 Oct;103(9):1343-1348.
2011-02	Phase II study of weekly low-dose everolimus plus weekly 24-hour infusions of cisplatin and high-dose 5-fluorouracil and leucovorin for first-line treatment in patients with advanced gastric cancers	Journal of Clinical Oncology. 2011 Feb;29(4):Abstract Number 86.
2004-08-02	Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer	British Journal of Cancer. 2004 Aug;91(3):453-458.
2005	Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer	Oncology. 2005;69(1):88-95.
2005-03-28	Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer	British Journal of Cancer. 2005 Mar;92(6):1013-1018.
2000-12	Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer	Lung Cancer. 2000 Dec;30(3):199-202.
2003-04	Phase II study with vinorelbine and cisplatin in advanced non-small cell lung cancer after failure of previous chemotherapy	Journal of the Chinese Medical Association. 2003 Apr;66(4):241-246.
2009-12	A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma	Cancer Chemotherapy and Pharmacology. 2009 Dec;65(1):151-157.
2006-06	A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy	Lung Cancer. 2006 Jun;52(3):333-338.
1998-03	Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions	Respiratory Medicine. 1998 Mar;92(3):473-479.
2022-07	A phase II trial of nivolumab, gemcitabine and S-1 as the frst-line treatment in patients with biliary tract cancer	Annals of Oncology. 2022 Jul;33(Suppl. 6):S478.
2007-09	A phase II trial of oxaliplatin with high-dose of 5-fluorouracil and leucovorin in the first-line treatment of inoperable, locally advanced or metastatic biliary tract cancer	EJC Supplements. 2007 Sep;5(4):268.
2000-02	A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer	American Journal of Clinical Oncology. 2000 Feb;23(1):13-17.
2005-06	A phase II trial of UFUR plus gemcitabine in non-small cell lung cancer patients failing previous platinum-based chemotherapy	Journal of Clinical Oncology. 2005 Jun;23(16):Abstract number 694S.
2000-02	A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non-small-cell lung cancer	American Journal of Clinical Oncology. 2000 Feb;23(1):60-64.
2003-05	A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older	Lung Cancer. 2003 May;40(2):221-226.
2016-05	Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC)	Journal of Clinical Oncology. 2016 May;34(15, Suppl. S):Abstract number 4017.
2018-06	Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma	Annals of Oncology. 2018 Jun;29(6):1402-1408.

Showing items 9051-9100 of 12927. (259 Page(s) Totally) << < 177 178 179 180 181 182 183 184 185 186 > >> View [10|25|50] records per page